Study of the effect of continuous intravenous lidocaine infusion on postoperative recovery in thoracoscopic patients

A study of the effect of continuous intravenous lidocaine infusion versus a single parathracic block combined with opioid thoracoscopy in patients with postoperative recovery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200055868

Enrollment

Unknown

Registered

2022-01-22

Start date

2022-01-19

Completion date

Unknown

Last updated

2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative recovery

Interventions

TPVB Group:Continuous intravenous lidocaine infusion

LIDO Group:Single thoracic paravertebral nerve block combined with opioids

Eligibility

Sex/Gender

All

Age

No minimum to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with thoracoscopic surgery and general anesthesia; 2. Patients aged 80 years and over; 3. Patients with ASA I to III grade; 4. Patients stay in hospital for at least 48 hours after surgery.

Exclusion criteria

Exclusion criteria: 1. Abnormal heart, lung, liver, kidney and coagulation function (including unstable ischemic heart disease; Arrhythmias; Complete bundle branch block; QT interval prolongation; Heart failure, etc.); 2. Patients with infection in the proposed block area and severe nerve damage to the blocking lateral limb; 3. Patients with a history of chronic pain taking analgesic drugs, taking psychotics, radiotherapy and chemotherapy, contraindicated to nonsteroidal anti-inflammatory drugs; 4. Repeat surgery or planned re-operation within 30 days after surgery; 5. Patients who are allergic to local anesthetics such as lidocaine, ropivacaine, and general anesthetic drugs; 6. Serum potassium abnormalities; 7. Patients and their families who refuse surgical anesthesia and are unable to complete the questionnaire.

Design outcomes

Primary

Measure	Time frame
QoR-40;	—

Countries

China

Contacts

Public ContactZhou Qinghe

Jiaxing First Hospital

jxxmxy@163.com+86 13732573379

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026